DLK Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
SMDAM
CRM
FWCM
DLK Investment Management's AMGN Position: Q2 2026 in Review
DLK Investment Management reduced its Amgen (AMGN) stake by 6.2% in Q2 2026, selling an estimated $432K and leaving 19,109 shares worth $5.97M. The position accounts for 2.54% of the portfolio, ranked #12.
DLK Investment Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.17M in Q1 2026. 889 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- DLK Investment Management held 19,109 shares of Amgen worth $5.97M as of Q2 2026.
- DLK Investment Management sold 1,261 Amgen shares in Q2 2026, an estimated $432K.
- Amgen made up 2.54% of DLK Investment Management's portfolio in Q2 2026, its #12 holding.
- DLK Investment Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- DLK Investment Management's Amgen position peaked at $7.17M in Q1 2026.
- 889 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.